CJC-1295 W/O DAC 5mg +5mg Ipamorelin

This CJC‑1295 (Without DAC) + Ipamorelin 1:1 blend combines two well‑studied research peptides frequently used in scientific investigations involving growth‑hormone–releasing pathways, pituitary signaling, and peptide interaction models.

CJC‑1295 (W/O DAC) is known for its short‑acting profile, making it valuable for studies focused on pulsatile GH‑release patterns and rapid‑response signaling events.
Ipamorelin, a selective ghrelin mimetic, is commonly evaluated for its receptor specificity, clean signaling profile, and targeted influence on GH‑related pathways.

Together, this blend provides researchers with a controlled, synergistic model for exploring peptide combinations, receptor responses, and hormone‑signaling dynamics.

Supplied as a high‑purity, lyophilized powder, this blend is designed for maximum stability in laboratory environments.

For laboratory research use only. Not for human consumption.